Clinical Trials on Non-Small Cell Lung Cancer, Lung Cancer, Cancer in Belgium
Total 590 results
-
Centre Hospitalier Universitaire de LiegeActive, not recruitingNon-small Cell Lung CancerBelgium
-
University Hospital, GhentUniversity Ghent; Kom Op Tegen KankerActive, not recruitingNon-small Cell Lung CancerBelgium
-
Hasselt UniversityJessa Hospital; University Hospital, Ghent; University GhentRecruitingNon-small Cell Lung Cancer | Non-small Cell CarcinomaBelgium
-
Universitair Ziekenhuis BrusselRecruitingNon-small Cell Lung CancerBelgium
-
University Hospital, GhentNationaal KankerplanTerminatedInoperable Early Stage Non-small Cell Lung CancerBelgium
-
University Hospital, GhentUniversity Ghent; Kom Op Tegen KankerActive, not recruitingNon-small Cell Lung Cancer MetastaticBelgium
-
University Hospital, GhentHasselt University; Jessa Hospital; AZ Sint-Jan AV; AZ Delta; Ziekenhuis Oost-LimburgRecruitingNon Small Cell Lung Cancer | Non-small Cell CarcinomaBelgium
-
ETOP IBCSG Partners FoundationHoffmann-La RocheTerminatedNon-small Cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer RecurrentIreland, Spain, Belgium, Italy, Netherlands, Switzerland
-
University Hospital, AntwerpSanofi; Universiteit AntwerpenCompletedNon-small Cell Lung CancerBelgium
-
University Hospital, AntwerpEli Lilly and Company; Universiteit AntwerpenCompletedNon-Small-Cell-Lung CancerBelgium
-
European Organisation for Research and Treatment...UnknownNon-small Cell Lung Cancer Stage I | Non-small Cell Lung Cancer Stage IIGermany, Belgium, United Kingdom, Switzerland
-
Universitaire Ziekenhuizen KU LeuvenRecruitingNon-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor ReceptorBelgium
-
University Hospital, GhentNationaal KankerplanTerminatedEarly Stage Non-small Cell Lung CancerBelgium
-
Jules Bordet InstituteRecruitingNon Small Cell Lung CancerBelgium
-
Vrije Universiteit BrusselKom Op Tegen KankerUnknownLung Cancer, Non-small CellBelgium
-
Eli Lilly and CompanyCompleted
-
Universitair Ziekenhuis BrusselRecruitingNon Small Cell Lung CancerBelgium
-
Novartis PharmaceuticalsCompletedNon Small Cell Lung CancerBelgium, Australia, Germany
-
Centre Hospitalier Universitaire de LiegeRecruitingNon-small Cell Lung CancerBelgium
-
University Hospital, GasthuisbergCompletedLung Cancer | Non Small Cell Lung CancerBelgium
-
Thoraxklinik-Heidelberg gGmbHCompletedNon Small Cell Lung CancerBelgium, Germany, Luxembourg
-
Synta Pharmaceuticals Corp.TerminatedNon-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage IIIB | Non-small Cell Lung Cancer Stage IVUnited States, Belgium, Bosnia and Herzegovina, Canada, Croatia, Czech Republic, Germany, Poland, Romania, Russian Federation, Serbia, Spain, United Kingdom
-
Universitair Ziekenhuis BrusselRecruitingSolid Tumor | Non Small Cell Lung CancerBelgium
-
GenmabTerminatedNon Small Cell Lung CancerBelgium, United States, France, Netherlands, United Kingdom
-
Eli Lilly and CompanyWithdrawnMetastatic Squamous Non-Small Cell Lung Cancer | Locally Advanced Squamous Non-Small Cell Lung CancerItaly, Romania, Germany, Belgium, Russian Federation, United States, United Kingdom
-
AstraZenecaCompletedAdvanced Non Small Cell Lung Cancer | Advanced (Inoperable) Non Small Cell Lung CancerBelgium, United States, Korea, Republic of, Taiwan, United Kingdom, Netherlands
-
Maastricht Radiation OncologyUniversitaire Ziekenhuizen KU LeuvenCompletedNon Small Cell Lung CancerNetherlands, Belgium
-
TransgeneBristol-Myers SquibbCompletedNon Small Cell Lung Cancer MetastaticHungary, France, United States, Belgium
-
Hoffmann-La RocheCompleted
-
University Hospital, AntwerpAstraZeneca; Universiteit AntwerpenCompletedNon Small Cell Lung CancerBelgium
-
European Organisation for Research and Treatment...Terminated
-
University Hospital, AntwerpUniversiteit Antwerpen; Belgian Cancer RegistryEnrolling by invitationSmoking Cessation | Lung Cancer | Lung Cancer, Nonsmall Cell | Lung Cancer, Small CellBelgium
-
PDC*line Pharma SASActive, not recruitingSafety, Immunogenicity and Preliminary Clinical Activity Study of PDC*lung01 Cancer Vaccine in NSCLCNon Small Cell Lung CancerBelgium, France, Netherlands, Germany, Poland
-
GlaxoSmithKlineCompletedNon-Small-Cell Lung CancerUnited States, Belgium, United Kingdom
-
Peregrine PharmaceuticalsCompletedCarcinoma, Non-Small-Cell Lung | Non-Small Cell Lung Cancer | Nonsmall Cell Lung Cancer | Non-Small-Cell Lung Carcinoma | Non-Small-Cell Lung Cancer Stage IIIB | Non-Small-Cell Lung Cancer Stage IV | Non-Small-Cell Lung Cancer MetastaticUnited States, Australia, Belgium, France, Germany, Greece, Hungary, Italy, Korea, Republic of, Romania, Russian Federation, Spain, Taiwan, Ukraine
-
Leiden University Medical CenterJessa Hospital; The Netherlands Cancer InstituteRecruitingImmunotherapy | Non Small Cell Lung Cancer Stage IIINetherlands, Belgium
-
Bristol-Myers SquibbTerminatedNon-small Cell Lung CancerSpain, United States, Belgium, France, Italy, Netherlands, United Kingdom
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Completed
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerHong Kong, Spain, Russian Federation, France, Bulgaria, Germany, Estonia, Italy, Poland, Taiwan, United Kingdom, Singapore, Ireland, Belgium
-
Martin-Luther-Universität Halle-WittenbergRadiation Oncology Working Group of the German Cancer SocietyCompletedNon Small Cell Lung Cancer Stage IIIGermany, Austria, Belgium, Spain, Switzerland
-
Novartis PharmaceuticalsTerminatedSquamous Non-small Cell Lung CancerGermany, Spain, Korea, Republic of, Belgium, Italy, United States, France, Sweden
-
MSD Belgium BVBACompletedStage IV Non-small Cell Lung CancerBelgium
-
AZ-VUBUnknownCancers Harbouring an EGFR Mutation, (Excluding Non-squamous Non- Small Cell Lung Cancer, a Registered Indication), a HER2 Mutation or a HER3 MutationBelgium
-
Bristol-Myers SquibbActive, not recruitingNon-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Metastatic Non-small Cell Lung CancerAustralia, Russian Federation, United States, Argentina, Austria, Belgium, Brazil, Chile, France, Germany, Italy, Mexico, Poland, Romania, Spain, Switzerland, United Kingdom, Ireland, Netherlands
-
University Hospital, AntwerpEli Lilly and Company; Universiteit AntwerpenCompleted
-
Mirati Therapeutics Inc.RecruitingAdvanced Non-Small Cell Lung Cancer | Metastatic Non-Small Cell Lung CancerUnited States, Korea, Republic of, Italy, Spain, Czechia, Hungary, Netherlands, Canada, Australia, Austria, Belgium, Germany, Ireland, Israel, Poland, United Kingdom, Taiwan, Portugal
-
SanofiActive, not recruitingNon-squamous Non-small Cell Lung CancerBelgium, Italy, Spain, Japan, United States, France, Turkey
-
Eli Lilly and CompanyCompletedNon-small Cell Lung CancerItaly, United States, Germany, Poland, Belgium, United Kingdom
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerBelgium, Spain, United Kingdom, Germany, Italy, Poland, France
-
AstraZenecaActive, not recruitingMetastatic Non-Small Cell Lung Cancer (NSCLC)United States, Spain, Belgium, Poland, Taiwan, Thailand, Korea, Republic of, Russian Federation, Austria